- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Transanal endoscopic microsurgery yields better long term outcomes in rectal neuroendocrine tumors
China: When it comes to the treatment of tiny rectal neuroendocrine tumors (RNET), transanal endoscopic microsurgery (TEM) provides good long-term results and minimal anal function disruption. Incomplete endoscopic excision is also a good candidate for TEM as salvage therapy, says a study published in BMC Surgery.
TEM is widely used to treat local rectal lesions all around the world. Wei-Kun Shi and colleagues set out to evaluate the effectiveness and safety of TEM in the treatment of RNET in this study.
Patients who received TEM for RNET at Peking Union Medical College Hospital, Bejing, China between December 2006 and June 2019 were studied retrospectively. Anal function surveys, demographic and tumour features, surgical and pathological information, complications, and follow-up data were all included.
The key findings of this study were as follow:
1. A total of 144 patients were enrolled in the study. In 54 cases, TEM was used as the main excision, 57 patients had endoscopic forceps biopsy, and 33 patients had incomplete resection by endoscopic excision.
2. The median size of all initial tumors was 0.6 cm, and 142 patients had a negative resection margin.
3. Three patients had postoperative problems, which were effectively handled using a conservative approach.
4. Three patients died of other reasons after a median follow-up of 75.5 months following surgery, and two patients developed metastases.
5. 24 months following the TEM, an anal function questionnaire was presented. Three patients (2.1%) experienced significant low anterior resection syndrome (LARS), including one (0.7%) who had full incontinence, while six patients (4.2%) had minor LARS.
6. Five months after TEM, one patient in the biopsy group had local metastases, necessitating extensive surgery. The pathological grade of the lymphatic metastasis-positive tumor was G2, however the biopsy material and tumor tissue removed via TEM were both G1, indicating that this tumor was likely made up of two grades, with G1 being the majority.
In conclusion, TEM is a successful treatment for RNET less than 2 cm in size, however it has a deleterious impact on anal function. Positive margins following endoscopic resection are suitable candidates for TEM.
Reference:
Shi, WK., Hou, R., Li, YH. et al. Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors. BMC Surg 22, 43 (2022). https://doi.org/10.1186/s12893-022-01494-2
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751